KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Clarification on Previous ASX Announcement, page-83

  1. 1,346 Posts.
    lightbulb Created with Sketch. 17
    I think Kelly's plan was too high risk. Novogen is big enough to get through Phase 1 and 2 trials but not big enough to get through Phase 3. Could the company survive a failure in Phase 3 trial - I don't think it could. They need to find partners otherwise a Phase 3 failure would cripple the company and wreck the rest of the pipelines.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.